24:I[7748,["268","static/chunks/aaea2bcf-705c747c36d33c22.js","839","static/chunks/839-631463a41726f237.js","320","static/chunks/320-fa817057570f2b68.js","551","static/chunks/app/article/%5Bid%5D/page-b53fad440e632bf3.js"],"default"] 25:I[6437,["268","static/chunks/aaea2bcf-705c747c36d33c22.js","839","static/chunks/839-631463a41726f237.js","320","static/chunks/320-fa817057570f2b68.js","551","static/chunks/app/article/%5Bid%5D/page-b53fad440e632bf3.js"],"default"] 28:I[5504,["268","static/chunks/aaea2bcf-705c747c36d33c22.js","839","static/chunks/839-631463a41726f237.js","320","static/chunks/320-fa817057570f2b68.js","551","static/chunks/app/article/%5Bid%5D/page-b53fad440e632bf3.js"],"default"] 26:T6bc,

STOCKHOLM, Jan. 7, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that management will present at and participate in the 42nd Annual J.P. Morgan Healthcare Conference, which is taking place January 8-11, 2024, in San Francisco, California. Calliditas will present an update on the company at 7:30 am PT on Tuesday 9th January.

For further information, please contact:

Åsa Hillsten, Head of IR & Sustainability, Calliditas

Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com

The information was sent for publication, through the agency of the contact person set out above, on January 7, 2024 at 3:00 p.m. CET.

About Calliditas

Calliditas Therapeutics is a biopharma company headquartered in Stockholm, Sweden, focused on identifying, developing, and commercializing novel treatments in orphan indications with significant unmet medical needs. Calliditas' common shares are listed on Nasdaq Stockholm (ticker: CALTX) and its American Depositary Shares are listed on the Nasdaq Global Select Market (ticker: CALT). Visit Calliditas.com for further information.

The following files are available for download:

Tags

More Like This

Calliditas to present at upcoming investor conferences

Calliditas Therapeutics to Attend Investor Conferences in March

Calliditas Therapeutics to Attend Conferences in April

Calliditas Therapeutics provides business update ahead of JP Morgan conference

Calliditas Therapeutics' 2023 Annual Report Published

Invitation to the presentation of Calliditas´s interim report January - March 2024

Invitation to the presentation of Calliditas´s interim report January - June 2024

Invitation to the presentation of Calliditas´ Year-end report January - December 2023